United States · FDA National Drug Code directory

Prevacid

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 64764-046_45f1d5ff-d884-4e40-a16c-313a4e21e32c
Product NDC: 64764-046
Form: CAPSULE, DELAYED RELEASE
Composition / generic term: lansoprazole
Labeler: Takeda Pharmaceuticals America, Inc.
Marketing category: NDA
Marketing start / end (source format): 19950510
Source listing expiry: 20261231

Source-listed ingredients

LANSOPRAZOLE — 30 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

5 BLISTER PACK in 1 TRAY (64764-046-06) / 4 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK · 64764-046-06
100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-046-13) · 64764-046-13

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →